Fig. 4: The expression of miR-297 in liver cancer patient tissues.
From: MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3
A Representative IHC staining of miR-297 in liver cancer patient tissues and adjacent non-cancerous tissues. B MiR-297 levels have a tendency to decrease in the cancer tissues compared with the noncancerous tissues, but there are no statistically significant differences. C The proportion of the four groups: negative staining; low staining; moderate staining and high staining between the cancer and non-cancerous tissues showed no significant difference. D The expression of miR-297 in p53 negative(p53-) and positive(p53+) group.
